Synopsis of recent research by authors named "Gary B Gordon"
- Gary B. Gordon's research primarily focuses on the development and clinical evaluation of targeted cancer therapies, particularly the pharmacokinetics and efficacy of drugs like venetoclax, ABT-751, and navitoclax in hematological malignancies and solid tumors.
- His studies emphasize the integration of pharmacogenetic approaches to optimize drug efficacy and safety for individualized patient care, as seen in trials of ABT-751 and assessment of its metabolites in relation to UGT and SULT enzymes.
- Additionally, Gordon's work includes investigating supportive care measures in oncology, such as the impact of misoprostol on chemotherapy-induced oral mucositis and exploring chemopreventive strategies for skin cancer with celecoxib.
